Interactions between neural membrane glycerophospholipid and sphingolipid mediators: A recipe for neural cell survival or suicide
- 28 March 2007
- journal article
- review article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 85 (9) , 1834-1850
Abstract
The neural membranes contain phospholipids, sphingolipids, cholesterol, and proteins. Glycerophospholipids and sphingolipids are precursors for lipid mediators involved in signal transduction processes. Degradation of glycerophospholipids by phospholipase A2(PLA2) generates arachidonic acid (AA) and docosahexaenoic acids (DHA). Arachidonic acid is metabolized to eicosanoids and DHA is metabolized to docosanoids. The catabolism of glycosphingolipids generates ceramide, ceramide 1‐phosphate, sphingosine, and sphingosine 1‐phosphate. These metabolites modulate PLA2activity. Arachidonic acid, a product derived from glycerophospholipid catabolism by PLA2, modulates sphingomyelinase (SMase), the enzyme that generates ceramide and phosphocholine. Furthermore, sphingosine 1‐phosphate modulates cyclooxygenase, an enzyme responsible for eicosanoid production in brain. This suggests that an interplay and cross talk occurs between lipid mediators of glycerophospholipid and glycosphingolipid metabolism in brain tissue. This interplay between metabolites of glycerophospholipid and sphingolipid metabolism may play an important role in initiation and maintenance of oxidative stress associated with neurologic disorders as well as in neural cell proliferation, differentiation, and apoptosis. Recent studies indicate that PLA2and SMase inhibitors can be used as neuroprotective and anti‐apoptotic agents. Development of novel inhibitors of PLA2and SMase may be useful for the treatment of oxidative stress, and apoptosis associated with neurologic disorders such as stroke, Alzheimer disease, Parkinson disease, and head and spinal cord injuries.Keywords
This publication has 157 references indexed in Scilit:
- Cross Talk between Sphingolipids and Glycerophospholipids in the Establishment of Plasma Membrane AsymmetryMolecular Biology of the Cell, 2004
- Inhibition of sphingomyelinase activity helps to prevent neuron death caused by ischemic stressNeurochemistry International, 2004
- A potentially critical role of phospholipases in central nervous system ischemic, traumatic, and neurodegenerative disordersBrain Research Reviews, 2004
- Amyloid-β peptide induces oligodendrocyte death by activating the neutral sphingomyelinase–ceramide pathwayJournal of Cell Biology, 2004
- Nerve Growth Factor-induced Glutamate Release Is via p75 Receptor, Ceramide, and Ca2+ from Ryanodine Receptor in Developing Cerebellar NeuronsJournal of Biological Chemistry, 2003
- Modulation of Caspase-3 Activity by Zinc Ions and by the Cell Redox StateExperimental Cell Research, 2001
- Bcl-x L Suppresses TNF-Mediated Apoptosis and Activation of Nuclear Factor-κB, Activation Protein-1, and c-Jun N-Terminal KinaseJournal of Interferon & Cytokine Research, 2000
- Role of Ceramide in Stimulation of the Transcription of Cytosolic Phospholipase A2and Cyclooxygenase 2Biochemical and Biophysical Research Communications, 1996
- Elevated cPLA2 levels as a mechanism by which the p70 TNF and p75 NGF receptors enhance apoptosisFEBS Letters, 1996
- Identification and Purification of Calcium‐Independent Phospholipase A2 from Bovine Brain CytosolJournal of Neurochemistry, 1992